theadanews.com - Ada, Oklahoma

National and World

February 23, 2013

Breast cancer drug approved by FDA

Washington, DC —  

The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.

The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a potent dose of anti-tumor poison.

Cancer researchers say the drug is an important step forward because it delivers more medication while reducing the unpleasant side effects of chemotherapy.

“This antibody goes seeking out the tumor cells, gets internalized and then explodes them from within. So it’s very kind and gentle on the patients — there’s no hair loss, no nausea, no vomiting,” said Dr. Melody Cobleigh of Rush University Medical Center. “It’s a revolutionary way of treating cancer.”

Cobleigh helped conduct the key studies of the drug at the Chicago facility.

The FDA approved the new treatment for about 20 percent of breast cancer patients with a form of the disease that is typically more aggressive and less responsive to hormone therapy. These patients have tumors that overproduce a protein known as HER-2. Breast cancer is the second most deadly form of cancer in U.S. women, and is expected to kill more than 39,000 Americans this year, according to the National Cancer Institute.

The approval will help Roche’s Genentech unit build on the blockbuster success of Herceptin, which has long dominated the breast cancer marketplace. The drug had sales of roughly $6 billion last year.

Genentech said Friday that Kadcyla will cost $9,800 per month, compared to $4,500 per month for regular Herceptin. The company estimates a full course of Kadcyla, about nine months of medicine, will cost $94,000.

FDA scientists said they approved the drug based on company studies showing Kadcyla delayed the progression of breast cancer by several months. Researchers reported last year that patients treated with the drug lived 9.6 months before death or the spread of their disease, compared with a little more than six months for patients treated with two other standard drugs, Tykerb and Xeloda.

Text Only | Photo Reprints
National and World
  • Dozens injured as explosions rock Boston Marathon

    At least two explosions occurred at 2:50 p.m. Monday near the finish line at the Boston Marathon, injuring dozens of spectators.

    April 15, 2013

  • Saturday for Now Saturday delivery will continue — for now

     

    People who check their mailboxes for magazines, catalogs and bills on Saturdays can continue that part of their weekend routine — at least for now.

     

    April 12, 2013 1 Photo

  • Officials warn of salmonella dangers from baby poultry

    Easter and the spring season is the time of year when baby poultry, including chicks, ducklings, goslings, and baby turkeys are given as gifts or put on display in stores for children to touch and hold. 

    March 26, 2013

  • Tom Cole Republicans submit budget

    House Republicans presented our annual budget blueprint last week, followed the next day by Senate Democrats.  The contrast between the two plans could not be more stark.

    March 20, 2013 1 Photo

  • Norovirus Doctor warns norovirus spreads easily

     

    With the country in the midst of a record year for influenza cases, doctors at the Oklahoma Medical Research Foundation are warning Oklahomans to watch out for another violent and virulent illness called the norovirus.

     

    February 28, 2013 1 Photo

  • 19 killed in fiery air balloon accident

     

    The terror lasted less than two minutes: Smoke poured from a hot air balloon carrying sightseers on a sunrise flight over the ancient city of Luxor. The balloon burst in a flash of flame and then plummeted about 1,000 feet to earth. A farmer watched helplessly as tourists trying to escape the blazing gondola leaped to their deaths.

     

    February 27, 2013

  • Breast cancer drug approved by FDA

     

    The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.

     

    February 23, 2013

  • State of the Nations Women’s security raised by American Indian leader

    The president of the National Congress of American Indians urged the House on Thursday to pass the Violence Against Women Act so Native Americans and Alaska Natives can “protect their own people and surrounding communities against brutality.”

    February 15, 2013 1 Photo

  • Pope's resignation no shock to Ada woman Pope's resignation no shock to Ada woman

     

    Unlike many Catholics, Linda Schaefer was not shocked to learn that Pope Benedict XVI is retiring at the end of this month.

     

    February 14, 2013 1 Photo

  • No Saturday delivery

     

    The U.S. Postal Service’s decision to eliminate weekend delivery will affect businesses that send out bills and receive payments in the mail, said Mellanie Jones, marketing director for Rolling Hills Hospital in Ada.

     

    February 7, 2013

AP Video
Captain of Sunken SKorean Ferry Arrested Raw: Fire Destroys 3 N.J. Beachfront Homes Raw: Pope Presides Over Good Friday Mass Raw: Space X Launches to Space Station Superheroes Descend on Capitol Mall Man Charged in Kansas City Highway Shootings Obama Awards Navy Football Trophy Anti-semitic Leaflets Posted in Eastern Ukraine Raw: Magnitude-7.2 Earthquake Shakes Mexico City Ceremony at MIT Remembers One of Boston's Finest Raw: Students Hurt in Colo. School Bus Crash Raw: Church Tries for Record With Chalk Jesus Raw: Faithful Celebrate Good Friday Worldwide Deadly Avalanche Sweeps Slopes of Mount Everest Police Arrest Suspect in Highway Shootings Drought Concerns May Hurt Lake Tourism Vermont Goat Meat Gives Refugees Taste of Home Calif. Investigators Re-construct Fatal Bus Cras Mayor Rob Ford Launches Re-election Campaign Appellate Court Hears Okla. Gay Marriage Case
Stocks
Poll

For years, Oklahoma was a mostly Democratic state. In recent years, there has been a swing to Republican affiliation. Have you changed your political affiliation to Republican?

Yes
No
     View Results